Health Library

Allergies
Aging
Cancer
Diabetes
Exercise
Heart health
Infectious diseases
Nutrition
Stroke

 

Single drug treatment for malaria to be phased out

Accra, June 7, Ghanadot/GNA - The Food and Drugs Board (FDB) is no longer registering new anti-malaria mono-therapies, or single drug, for use in the management of malaria.


The regulatory body said the licenses of mono-therapies already in existence would not be renewed once their term expired, as part of measures to phase them out after a set period.


FDB officials told the GNA in Accra on Thursday that this was in conformity with policy directions to phase out mono-therapies in favour of combination therapies.


Currently, there are a variety of mono-therapies such artesunate, chloroquine, amodiaquine, alaxin and halufantrine in the system but the registration licenses of majority of these drugs are expected to expire by the end of the year.


Following problems of resistance and failure rate of chloroquine, the World Health Organization has recommended the use of a combination of more than one drug to treat malaria.


The world body has accepted the use of an artemisinin and other anti-malarial drugs, ushering in a regime of artemisinin-based combination therapies (ACTs) for treatment of malaria.


The four ACTs recommended by the WHO for Africa are:

  • Artesunate-fansidar

  • Artesunate-amodiaquine

  • Artesunate-mefloquine and

  • Artemether-lumefantrine, known also as coartem.

Eighteen countries including Ghana, Cameroon, Liberia, Sierra Leone and DR Congo, have opted for artesunate-amodiaquine, as a first line malaria drug while 21 countries including Kenya, South Africa, Mali and Nigeria have gone for artemether-lumefantrine.


Meanwhile, Mr Nelson Aklamanu, a pharmacist at the Palace Pharmacy at Danquah Circle in Accra, has called for a possible trial into reasons why children experience little side effects as compared to adult patients when they go on artesunate amodiaquine.


He told the GNA that most adult patients who visited his pharmacy opted for other malaria drugs, especially artemether-lumefantrine, because of adverse effects of sleeplessness, palpitation and others they experienced after taking artesunate-amodiaquine.


He said children, surprisingly, tolerated artesunate-amodiaquine with very little complaints.


GNA


 

Google
 
Web www.ghanadot.com


Archived Articles :: 2005

Fungi native to East Africa could be used in fight against malaria
BBC:

 

 


Archived Articles :: 2003

Archived Articles :: 2002

 

 

 

Parliament goes on break for December polls

Accra, Nov. 14, Ghanadot/GNA - Parliament on Friday before it began a break in readiness for the December polls, reminded the Electoral Commission (EC) that it had a crucial role to make the forthcoming Presidential and Parliamentary elections peaceful.
.
.More
  Home mortgage financing law passed

Accra, Nov. 13, Ghanadot/GNA – Parliament on Thursday passed a bill that would provide a uniform system of home mortgage financing into law.
.... More
   
Librarians want in on copyright issues

Accra, Nov. 13, Ghanadot/GNA - Mrs Valentina Bannerman, President of the Ghana Library Association, has appealed to government to consider the participation of librarians in any national and international forum where copyright issues are discussed in order to make their voices heard.
.....More
  NDC Central Regional Secretariat threatens to sue EC over votes transfer

Cape Coast, Nov. 13, Ghanadot/GNA - Mr Ebo Barton-Odro, National Democratic Congress (NDC) Parliamentary Candidate for Cape Coast Constituency on Thursday, threatened that the Party would sue the Electoral Commission (EC) if it failed to furnish it with particulars ...More 
   
  ABC, Australia
FOXNews.com
The EastAfrican, Kenya
African News Dimensions
Chicago Sun Times
The Economist
Reuters World
CNN.com - World News
All Africa Newswire
Google News
The Guardian, UK
Africa Daily
IRIN Africa
The UN News
Daily Telegraph, UK
Daily Nation, East Africa
BBC Africa News, UK
Legal Brief Africa
The Washington Post
BusinessInAfrica
Mail & Guardian, S. Africa
The Washington Times
Voice of America
CBSnews.com
New York Times
Vanguard, Nigeria
Christian Science Monitor
News24.com
Yahoo/Agence France Presse
 
  SPONSORSHIP AD HERE  
 
    Announcements
Debate
Commentary
Ghanaian Paper
Health
Market Place
News
Official Sites
Pan-African Page
Personalities
Reviews
Social Scene
Sports
Travel
 
    Currency Converter
Educational Opportunities
Job Opening
FYI
 
 

ThisWeekGhana.com becomes
GhanaDot.com
October 1, 2006

Remember to spell the D-O-T
before the dot com

 
Send This Page To A Friend:

The Profile Africa Media Group